More evidence on the limited impact of state oral oncology parity laws. Cancer 2019 Feb 01;125(3):335-336
Date
12/20/2018Pubmed ID
30566761Pubmed Central ID
PMC6361375DOI
10.1002/cncr.31904Scopus ID
2-s2.0-85058852796 (requires institutional sign-in at Scopus site) 3 CitationsAbstract
Most states have enacted legislation cancer parity laws in order to ensure that copayments are similar for cancer drugs whether the drug is administered orally or intravenously. However, the parity laws have had a limited impact, often only lower copayment for those that already had low copayments.
Author List
Winn AN, Dusetzina SBMESH terms used to index this publication - Major topics in bold
Breast NeoplasmsHumans
Insurance Coverage
Insurance, Health
